Global siRNA Drugs Supply, Demand and Key Producers, 2024-2030

Description

Small interfering RNA (siRNA), sometimes known as short interfering RNA or silencing RNA, is a class of double-stranded RNA at first non-coding RNA molecules, typically 20–24 (normally 21) base pairs in length, similar to miRNA, and operating within the RNA interference (RNAi) pathway. siRNA plays a crucial role in gene silencing and regulation of gene expression. siRNA-based therapeutics have gained significant attention in recent years due to their potential to target specific genes involved in diseases such as cancer, genetic disorders, viral infections, and neurodegenerative diseases. The scope of siRNA drug products encompasses various aspects, including their design, development, testing, and regulatory approval.

The global siRNA Drugs market size is expected to reach $ 12820 million by 2030, rising at a market growth of 31.2% CAGR during the forecast period (2024-2030).

Core manufacturers of siRNA Drugs include Alnylam, Novartis, Novo Nordisk, Genzyme and Arrowhead. USA is the largest consumption region, accounting for approximately 57% of the global market, followed by Europe. In terms of product type, subcutaneous injection are the largest market segment, with a share of more than 77%. In terms of product application, the largest application market is nervous system therapy, with a share of approximately 52%.

This report studies the global siRNA Drugs demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for siRNA Drugs, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of siRNA Drugs that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global siRNA Drugs total market, 2019-2030, (USD Million)
Global siRNA Drugs total market by region & country, CAGR, 2019-2030, (USD Million)
U.S. VS China: siRNA Drugs total market, key domestic companies, and share, (USD Million)
Global siRNA Drugs revenue by player, revenue and market share 2019-2024, (USD Million)
Global siRNA Drugs total market by Type, CAGR, 2019-2030, (USD Million)
Global siRNA Drugs total market by Application, CAGR, 2019-2030, (USD Million)
This report profiles major players in the global siRNA Drugs market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Alnylam, Novartis, Novo Nordisk, Genzyme, Arrowhead, Silence, Sylentis, Avidity Biosciences, Sirnaomics, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world siRNA Drugs market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global siRNA Drugs Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global siRNA Drugs Market, Segmentation by Type
    Intravenous Injection
    Subcutaneous Injection

Global siRNA Drugs Market, Segmentation by Application:
    Nervous System Therapy
    Endocrine and Metabolic Therapy
    Others

Companies Profiled:
    Alnylam
    Novartis
    Novo Nordisk
    Genzyme
    Arrowhead
    Silence
    Sylentis
    Avidity Biosciences
    Sirnaomics

Key Questions Answered
1. How big is the global siRNA Drugs market?
2. What is the demand of the global siRNA Drugs market?
3. What is the year over year growth of the global siRNA Drugs market?
4. What is the total value of the global siRNA Drugs market?
5. Who are the Major Players in the global siRNA Drugs market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 siRNA Drugs Introduction
    1.2 World siRNA Drugs Market Size & Forecast (2019 & 2023 & 2030)
    1.3 World siRNA Drugs Total Market by Region (by Headquarter Location)
        1.3.1 World siRNA Drugs Market Size by Region (2019-2030), (by Headquarter Location)
        1.3.2 United States Based Company siRNA Drugs Revenue (2019-2030)
        1.3.3 China Based Company siRNA Drugs Revenue (2019-2030)
        1.3.4 Europe Based Company siRNA Drugs Revenue (2019-2030)
        1.3.5 Japan Based Company siRNA Drugs Revenue (2019-2030)
        1.3.6 South Korea Based Company siRNA Drugs Revenue (2019-2030)
        1.3.7 ASEAN Based Company siRNA Drugs Revenue (2019-2030)
        1.3.8 India Based Company siRNA Drugs Revenue (2019-2030)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 siRNA Drugs Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Major Market Trends

2 Demand Summary
    2.1 World siRNA Drugs Consumption Value (2019-2030)
    2.2 World siRNA Drugs Consumption Value by Region
        2.2.1 World siRNA Drugs Consumption Value by Region (2019-2024)
        2.2.2 World siRNA Drugs Consumption Value Forecast by Region (2025-2030)
    2.3 United States siRNA Drugs Consumption Value (2019-2030)
    2.4 China siRNA Drugs Consumption Value (2019-2030)
    2.5 Europe siRNA Drugs Consumption Value (2019-2030)
    2.6 Japan siRNA Drugs Consumption Value (2019-2030)
    2.7 South Korea siRNA Drugs Consumption Value (2019-2030)
    2.8 ASEAN siRNA Drugs Consumption Value (2019-2030)
    2.9 India siRNA Drugs Consumption Value (2019-2030)

3 World siRNA Drugs Companies Competitive Analysis
    3.1 World siRNA Drugs Revenue by Player (2019-2024)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global siRNA Drugs Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for siRNA Drugs in 2023
        3.2.3 Global Concentration Ratios (CR8) for siRNA Drugs in 2023
    3.3 siRNA Drugs Company Evaluation Quadrant
    3.4 siRNA Drugs Market: Overall Company Footprint Analysis
        3.4.1 siRNA Drugs Market: Region Footprint
        3.4.2 siRNA Drugs Market: Company Product Type Footprint
        3.4.3 siRNA Drugs Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers & Acquisitions Activity

4 United States VS China VS Rest of World (by Headquarter Location)
    4.1 United States VS China: siRNA Drugs Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: siRNA Drugs Revenue Comparison (2019 & 2023 & 2030) (by Headquarter Location)
        4.1.2 United States VS China: siRNA Drugs Revenue Market Share Comparison (2019 & 2023 & 2030)
    4.2 United States Based Companies VS China Based Companies: siRNA Drugs Consumption Value Comparison
        4.2.1 United States VS China: siRNA Drugs Consumption Value Comparison (2019 & 2023 & 2030)
        4.2.2 United States VS China: siRNA Drugs Consumption Value Market Share Comparison (2019 & 2023 & 2030)
    4.3 United States Based siRNA Drugs Companies and Market Share, 2019-2024
        4.3.1 United States Based siRNA Drugs Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies siRNA Drugs Revenue, (2019-2024)
    4.4 China Based Companies siRNA Drugs Revenue and Market Share, 2019-2024
        4.4.1 China Based siRNA Drugs Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies siRNA Drugs Revenue, (2019-2024)
    4.5 Rest of World Based siRNA Drugs Companies and Market Share, 2019-2024
        4.5.1 Rest of World Based siRNA Drugs Companies, Headquarters (Province, Country)
        4.5.2 Rest of World Based Companies siRNA Drugs Revenue (2019-2024)

5 Market Analysis by Type
    5.1 World siRNA Drugs Market Size Overview by Type: 2019 VS 2023 VS 2030
    5.2 Segment Introduction by Type
        5.2.1 Intravenous Injection
        5.2.2 Subcutaneous Injection
    5.3 Market Segment by Type
        5.3.1 World siRNA Drugs Market Size by Type (2019-2024)
        5.3.2 World siRNA Drugs Market Size by Type (2025-2030)
        5.3.3 World siRNA Drugs Market Size Market Share by Type (2025-2030)

6 Market Analysis by Application
    6.1 World siRNA Drugs Market Size Overview by Application: 2019 VS 2023 VS 2030
    6.2 Segment Introduction by Application
        6.2.1 Nervous System Therapy
        6.2.2 Endocrine and Metabolic Therapy
        6.2.3 Others
    6.3 Market Segment by Application
        6.3.1 World siRNA Drugs Market Size by Application (2019-2024)
        6.3.2 World siRNA Drugs Market Size by Application (2025-2030)
        6.3.3 World siRNA Drugs Market Size Market Share by Application (2019-2030)

7 Company Profiles
    7.1 Alnylam
        7.1.1 Alnylam Details
        7.1.2 Alnylam Major Business
        7.1.3 Alnylam siRNA Drugs Product and Services
        7.1.4 Alnylam siRNA Drugs Revenue, Gross Margin and Market Share (2019-2024)
        7.1.5 Alnylam Recent Developments/Updates
        7.1.6 Alnylam Competitive Strengths & Weaknesses
    7.2 Novartis
        7.2.1 Novartis Details
        7.2.2 Novartis Major Business
        7.2.3 Novartis siRNA Drugs Product and Services
        7.2.4 Novartis siRNA Drugs Revenue, Gross Margin and Market Share (2019-2024)
        7.2.5 Novartis Recent Developments/Updates
        7.2.6 Novartis Competitive Strengths & Weaknesses
    7.3 Novo Nordisk
        7.3.1 Novo Nordisk Details
        7.3.2 Novo Nordisk Major Business
        7.3.3 Novo Nordisk siRNA Drugs Product and Services
        7.3.4 Novo Nordisk siRNA Drugs Revenue, Gross Margin and Market Share (2019-2024)
        7.3.5 Novo Nordisk Recent Developments/Updates
        7.3.6 Novo Nordisk Competitive Strengths & Weaknesses
    7.4 Genzyme
        7.4.1 Genzyme Details
        7.4.2 Genzyme Major Business
        7.4.3 Genzyme siRNA Drugs Product and Services
        7.4.4 Genzyme siRNA Drugs Revenue, Gross Margin and Market Share (2019-2024)
        7.4.5 Genzyme Recent Developments/Updates
        7.4.6 Genzyme Competitive Strengths & Weaknesses
    7.5 Arrowhead
        7.5.1 Arrowhead Details
        7.5.2 Arrowhead Major Business
        7.5.3 Arrowhead siRNA Drugs Product and Services
        7.5.4 Arrowhead siRNA Drugs Revenue, Gross Margin and Market Share (2019-2024)
        7.5.5 Arrowhead Recent Developments/Updates
        7.5.6 Arrowhead Competitive Strengths & Weaknesses
    7.6 Silence
        7.6.1 Silence Details
        7.6.2 Silence Major Business
        7.6.3 Silence siRNA Drugs Product and Services
        7.6.4 Silence siRNA Drugs Revenue, Gross Margin and Market Share (2019-2024)
        7.6.5 Silence Recent Developments/Updates
        7.6.6 Silence Competitive Strengths & Weaknesses
    7.7 Sylentis
        7.7.1 Sylentis Details
        7.7.2 Sylentis Major Business
        7.7.3 Sylentis siRNA Drugs Product and Services
        7.7.4 Sylentis siRNA Drugs Revenue, Gross Margin and Market Share (2019-2024)
        7.7.5 Sylentis Recent Developments/Updates
        7.7.6 Sylentis Competitive Strengths & Weaknesses
    7.8 Avidity Biosciences
        7.8.1 Avidity Biosciences Details
        7.8.2 Avidity Biosciences Major Business
        7.8.3 Avidity Biosciences siRNA Drugs Product and Services
        7.8.4 Avidity Biosciences siRNA Drugs Revenue, Gross Margin and Market Share (2019-2024)
        7.8.5 Avidity Biosciences Recent Developments/Updates
        7.8.6 Avidity Biosciences Competitive Strengths & Weaknesses
    7.9 Sirnaomics
        7.9.1 Sirnaomics Details
        7.9.2 Sirnaomics Major Business
        7.9.3 Sirnaomics siRNA Drugs Product and Services
        7.9.4 Sirnaomics siRNA Drugs Revenue, Gross Margin and Market Share (2019-2024)
        7.9.5 Sirnaomics Recent Developments/Updates
        7.9.6 Sirnaomics Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 siRNA Drugs Industry Chain
    8.2 siRNA Drugs Upstream Analysis
    8.3 siRNA Drugs Midstream Analysis
    8.4 siRNA Drugs Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
 Table 1. World siRNA Drugs Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
 Table 2. World siRNA Drugs Revenue by Region (2019-2024) & (USD Million), (by Headquarter Location)
 Table 3. World siRNA Drugs Revenue by Region (2025-2030) & (USD Million), (by Headquarter Location)
 Table 4. World siRNA Drugs Revenue Market Share by Region (2019-2024), (by Headquarter Location)
 Table 5. World siRNA Drugs Revenue Market Share by Region (2025-2030), (by Headquarter Location)
 Table 6. Major Market Trends
 Table 7. World siRNA Drugs Consumption Value Growth Rate Forecast by Region (2019 & 2023 & 2030) & (USD Million)
 Table 8. World siRNA Drugs Consumption Value by Region (2019-2024) & (USD Million)
 Table 9. World siRNA Drugs Consumption Value Forecast by Region (2025-2030) & (USD Million)
 Table 10. World siRNA Drugs Revenue by Player (2019-2024) & (USD Million)
 Table 11. Revenue Market Share of Key siRNA Drugs Players in 2023
 Table 12. World siRNA Drugs Industry Rank of Major Player, Based on Revenue in 2023
 Table 13. Global siRNA Drugs Company Evaluation Quadrant
 Table 14. Head Office of Key siRNA Drugs Players
 Table 15. siRNA Drugs Market: Company Product Type Footprint
 Table 16. siRNA Drugs Market: Company Product Application Footprint
 Table 17. siRNA Drugs Mergers & Acquisitions Activity
 Table 18. United States VS China siRNA Drugs Revenue Comparison, (2019 & 2023 & 2030) & (USD Million)
 Table 19. United States VS China siRNA Drugs Consumption Value Comparison, (2019 & 2023 & 2030) & (USD Million)
 Table 20. United States Based siRNA Drugs Companies, Headquarters (States, Country)
 Table 21. United States Based Companies siRNA Drugs Revenue, (2019-2024) & (USD Million)
 Table 22. United States Based Companies siRNA Drugs Revenue Market Share (2019-2024)
 Table 23. China Based siRNA Drugs Companies, Headquarters (Province, Country)
 Table 24. China Based Companies siRNA Drugs Revenue, (2019-2024) & (USD Million)
 Table 25. China Based Companies siRNA Drugs Revenue Market Share (2019-2024)
 Table 26. Rest of World Based siRNA Drugs Companies, Headquarters (Province, Country)
 Table 27. Rest of World Based Companies siRNA Drugs Revenue (2019-2024) & (USD Million)
 Table 28. Rest of World Based Companies siRNA Drugs Revenue Market Share (2019-2024)
 Table 29. World siRNA Drugs Market Size by Type, (USD Million), 2019 & 2023 & 2030
 Table 30. World siRNA Drugs Market Size Value by Type (2019-2024) & (USD Million)
 Table 31. World siRNA Drugs Market Size by Type (2025-2030) & (USD Million)
 Table 32. World siRNA Drugs Market Size by Application, (USD Million), 2019 & 2023 & 2030
 Table 33. World siRNA Drugs Market Size by Application (2019-2024) & (USD Million)
 Table 34. World siRNA Drugs Market Size by Application (2025-2030) & (USD Million)
 Table 35. Alnylam Basic Information, Manufacturing Base and Competitors
 Table 36. Alnylam Major Business
 Table 37. Alnylam siRNA Drugs Product and Services
 Table 38. Alnylam siRNA Drugs Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 39. Alnylam Recent Developments/Updates
 Table 40. Alnylam Competitive Strengths & Weaknesses
 Table 41. Novartis Basic Information, Manufacturing Base and Competitors
 Table 42. Novartis Major Business
 Table 43. Novartis siRNA Drugs Product and Services
 Table 44. Novartis siRNA Drugs Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 45. Novartis Recent Developments/Updates
 Table 46. Novartis Competitive Strengths & Weaknesses
 Table 47. Novo Nordisk Basic Information, Manufacturing Base and Competitors
 Table 48. Novo Nordisk Major Business
 Table 49. Novo Nordisk siRNA Drugs Product and Services
 Table 50. Novo Nordisk siRNA Drugs Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 51. Novo Nordisk Recent Developments/Updates
 Table 52. Novo Nordisk Competitive Strengths & Weaknesses
 Table 53. Genzyme Basic Information, Manufacturing Base and Competitors
 Table 54. Genzyme Major Business
 Table 55. Genzyme siRNA Drugs Product and Services
 Table 56. Genzyme siRNA Drugs Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 57. Genzyme Recent Developments/Updates
 Table 58. Genzyme Competitive Strengths & Weaknesses
 Table 59. Arrowhead Basic Information, Manufacturing Base and Competitors
 Table 60. Arrowhead Major Business
 Table 61. Arrowhead siRNA Drugs Product and Services
 Table 62. Arrowhead siRNA Drugs Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 63. Arrowhead Recent Developments/Updates
 Table 64. Arrowhead Competitive Strengths & Weaknesses
 Table 65. Silence Basic Information, Manufacturing Base and Competitors
 Table 66. Silence Major Business
 Table 67. Silence siRNA Drugs Product and Services
 Table 68. Silence siRNA Drugs Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 69. Silence Recent Developments/Updates
 Table 70. Silence Competitive Strengths & Weaknesses
 Table 71. Sylentis Basic Information, Manufacturing Base and Competitors
 Table 72. Sylentis Major Business
 Table 73. Sylentis siRNA Drugs Product and Services
 Table 74. Sylentis siRNA Drugs Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 75. Sylentis Recent Developments/Updates
 Table 76. Sylentis Competitive Strengths & Weaknesses
 Table 77. Avidity Biosciences Basic Information, Manufacturing Base and Competitors
 Table 78. Avidity Biosciences Major Business
 Table 79. Avidity Biosciences siRNA Drugs Product and Services
 Table 80. Avidity Biosciences siRNA Drugs Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 81. Avidity Biosciences Recent Developments/Updates
 Table 82. Avidity Biosciences Competitive Strengths & Weaknesses
 Table 83. Sirnaomics Basic Information, Manufacturing Base and Competitors
 Table 84. Sirnaomics Major Business
 Table 85. Sirnaomics siRNA Drugs Product and Services
 Table 86. Sirnaomics siRNA Drugs Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 87. Sirnaomics Recent Developments/Updates
 Table 88. Sirnaomics Competitive Strengths & Weaknesses
 Table 89. Global Key Players of siRNA Drugs Upstream (Raw Materials)
 Table 90. Global siRNA Drugs Typical Customers


List of Figures
 Figure 1. siRNA Drugs Picture
 Figure 2. World siRNA Drugs Total Revenue: 2019 & 2023 & 2030, (USD Million)
 Figure 3. World siRNA Drugs Total Revenue (2019-2030) & (USD Million)
 Figure 4. World siRNA Drugs Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
 Figure 5. World siRNA Drugs Revenue Market Share by Region (2019-2030), (by Headquarter Location)
 Figure 6. United States Based Company siRNA Drugs Revenue (2019-2030) & (USD Million)
 Figure 7. China Based Company siRNA Drugs Revenue (2019-2030) & (USD Million)
 Figure 8. Europe Based Company siRNA Drugs Revenue (2019-2030) & (USD Million)
 Figure 9. Japan Based Company siRNA Drugs Revenue (2019-2030) & (USD Million)
 Figure 10. South Korea Based Company siRNA Drugs Revenue (2019-2030) & (USD Million)
 Figure 11. ASEAN Based Company siRNA Drugs Revenue (2019-2030) & (USD Million)
 Figure 12. India Based Company siRNA Drugs Revenue (2019-2030) & (USD Million)
 Figure 13. siRNA Drugs Market Drivers
 Figure 14. Factors Affecting Demand
 Figure 15. World siRNA Drugs Consumption Value (2019-2030) & (USD Million)
 Figure 16. World siRNA Drugs Consumption Value Market Share by Region (2019-2030)
 Figure 17. United States siRNA Drugs Consumption Value (2019-2030) & (USD Million)
 Figure 18. China siRNA Drugs Consumption Value (2019-2030) & (USD Million)
 Figure 19. Europe siRNA Drugs Consumption Value (2019-2030) & (USD Million)
 Figure 20. Japan siRNA Drugs Consumption Value (2019-2030) & (USD Million)
 Figure 21. South Korea siRNA Drugs Consumption Value (2019-2030) & (USD Million)
 Figure 22. ASEAN siRNA Drugs Consumption Value (2019-2030) & (USD Million)
 Figure 23. India siRNA Drugs Consumption Value (2019-2030) & (USD Million)
 Figure 24. Producer Shipments of siRNA Drugs by Player Revenue ($MM) and Market Share (%): 2023
 Figure 25. Global Four-firm Concentration Ratios (CR4) for siRNA Drugs Markets in 2023
 Figure 26. Global Four-firm Concentration Ratios (CR8) for siRNA Drugs Markets in 2023
 Figure 27. United States VS China: siRNA Drugs Revenue Market Share Comparison (2019 & 2023 & 2030)
 Figure 28. United States VS China: siRNA Drugs Consumption Value Market Share Comparison (2019 & 2023 & 2030)
 Figure 29. World siRNA Drugs Market Size by Type, (USD Million), 2019 & 2023 & 2030
 Figure 30. World siRNA Drugs Market Size Market Share by Type in 2023
 Figure 31. Intravenous Injection
 Figure 32. Subcutaneous Injection
 Figure 33. World siRNA Drugs Market Size Market Share by Type (2019-2030)
 Figure 34. World siRNA Drugs Market Size by Application, (USD Million), 2019 & 2023 & 2030
 Figure 35. World siRNA Drugs Market Size Market Share by Application in 2023
 Figure 36. Nervous System Therapy
 Figure 37. Endocrine and Metabolic Therapy
 Figure 38. Others
 Figure 39. World siRNA Drugs Market Size Market Share by Application (2019-2030)
 Figure 40. siRNA Drugs Industrial Chain
 Figure 41. Methodology
 Figure 42. Research Process and Data Source

Companies Mentioned

Alnylam
Novartis
Novo Nordisk
Genzyme
Arrowhead
Silence
Sylentis
Avidity Biosciences
Sirnaomics